How does MDT's earnings growth compare to peers?

Medtronic's earnings growth, when compared to its peers, demonstrates a strong performance in terms of revenue and earnings growth rate.

1. **Revenue Growth Rate**: Medtronic's revenue growth rate of 14.9% for the fiscal quarter ending on March 31, 2025, surpasses its peers' growth rates, except for Royal Bank of Canada (RY), which has a higher growth rate of 31.07%. This indicates that Medtronic is outperforming most of its peers in terms of revenue expansion.

|code|Ticker|Name|Date|Total Revenue YoY|Diluted EPS YoY|market_code|
|---|---|---|---|---|---|---|
|MDT|MDT.N|Medtronic|2024 Q2|5.260382333553065|112.5|169|
|ABCL|ABCL.O|AbCellera Biologics|2024 Q2|-27.17780429594272|-18.181818181818183|185|
|MDT|MDT.N|Medtronic|2024 Q3|4.68487123074932|7.608695652173908|169|
|ABCL|ABCL.O|AbCellera Biologics|2024 Q3|-1.3941506288831642|-70|185|
|MDT|MDT.N|Medtronic|2024 Q4|0.526685393258427|-44.31818181818182|169|
|ABCL|ABCL.O|AbCellera Biologics|2024 Q4|-44.98311362893561||185|
|MDT|MDT.N|Medtronic|2025 Q1|2.765515450532329|35.593220338983066|169|

2. **Earnings Growth Rate**: The company's earnings growth rate of 2.02% is relatively modest compared to some peers, such as Royal Bank of Canada with a growth rate of 31.07%. However, it is important to note that Medtronic's earnings growth rate is positive, which is a sign of profitability and financial stability.
3. **Peer Comparison**: When compared to companies like Boston Scientific Corporation (SPB), which has a revenue growth rate of 2.51% and an earnings growth rate of -1.18%, Medtronic's growth rates are higher, suggesting better financial performance. Additionally, companies like New Providence II (NPAB) and AbCellera Biologics (ABCL) have negative earnings growth rates, which indicates that they may be facing challenges or have lower profitability compared to Medtronic.

In conclusion, Medtronic's earnings growth, particularly in terms of revenue, outperforms many of its peers. While there are companies with higher earnings growth rates, such as Royal Bank of Canada, Medtronic's overall financial growth rates position it well within the industry, reflecting its strong market position and operational efficiency.